StockData
Cardiol Therapeutics Inc. logo

Cardiol Therapeutics Inc. (CRDL) stock

CRDLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$0.86−0.02 (-2.28%)

Close on Nov 20, 2026Market cap $86.48MP/E –Yield –

Cardiol Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Cardiol Therapeutics's price to sales ratio was 396.3× on Feb 28, 2023.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Feb 28, 2023396.3×+17.6
2022Dec 30, 2022378.7×–

More Cardiol Therapeutics figures

See a number that looks wrong?